Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer

Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology demonstrates that blocking complement factor B (CFB), a pivotal enzyme in the alternative complement pathway, halts cancer growth and alters the tumor microenvironment. The greatest tumor suppression was observed when CFB inhibition was combined with…

Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Monday 9 November →